BG61931B1 - Фармацевтични състави, съдържащи производни на фурана - Google Patents

Фармацевтични състави, съдържащи производни на фурана Download PDF

Info

Publication number: BG61931B1
Authority: BG; Bulgaria
Prior art keywords: composition according; methyl; bismuth; ranitidine; complex
Prior art date: 1990-09-11

Application number

BG99021A

Other languages

Bulgarian (bg)

English (en)

Other versions

BG99021A (bg

Inventor

Stephen J. Douglas

Colin R. Heppenstall

Norman R. Smith

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-09-11

Filing date

1994-09-01

Publication date

1998-10-30

1994-09-01 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1995-06-30 Publication of BG99021A publication Critical patent/BG99021A/bg

1998-10-30 Publication of BG61931B1 publication Critical patent/BG61931B1/bg

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Saccharide Compounds (AREA)
Furan Compounds (AREA)

BG99021A 1990-09-11 1994-09-01 Фармацевтични състави, съдържащи производни на фурана BG61931B1 (bg)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB909019875A GB9019875D0 (en)	1990-09-11	1990-09-11	Pharmaceutical compositions
NO920408A NO179694C (no)	1990-09-11	1992-01-30	Farmasöytiske preparater inneholdende ranitidinderivater
PCT/EP1992/000498 WO1993017679A1 (fr)	1990-09-11	1992-03-05	Composition contenant un sel du type carboxylate de bismuth et de ranitidine

Publications (2)

Publication Number	Publication Date
BG99021A BG99021A (bg)	1995-06-30
BG61931B1 true BG61931B1 (bg)	1998-10-30

Family

ID=47884627

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG99021A BG61931B1 (bg)	1990-09-11	1994-09-01	Фармацевтични състави, съдържащи производни на фурана

Country Status (33)

Country	Link
US (1)	US5456925A (fr)
EP (1)	EP0558779B1 (fr)
JP (1)	JPH0692849A (fr)
KR (1)	KR100196308B1 (fr)
AT (2)	AT405134B (fr)
AU (2)	AU640816B2 (fr)
BE (1)	BE1005115A5 (fr)
BG (1)	BG61931B1 (fr)
CA (1)	CA2050970C (fr)
CH (1)	CH683068A5 (fr)
CY (1)	CY1988A (fr)
DE (2)	DE4130061A1 (fr)
DK (1)	DK159191A (fr)
ES (1)	ES2072647T3 (fr)
FI (1)	FI944047A0 (fr)
FR (1)	FR2666508B1 (fr)
GB (2)	GB9019875D0 (fr)
HK (1)	HK60894A (fr)
HU (1)	HU211846A9 (fr)
IE (1)	IE65049B1 (fr)
IL (1)	IL99428A (fr)
IT (1)	IT1249696B (fr)
MX (1)	MX9101009A (fr)
NL (1)	NL194907C (fr)
NO (1)	NO179694C (fr)
NZ (1)	NZ239731A (fr)
OA (1)	OA10093A (fr)
RO (1)	RO112084B1 (fr)
RU (1)	RU2108097C1 (fr)
SE (1)	SE509694C2 (fr)
SK (1)	SK279591B6 (fr)
WO (1)	WO1993017679A1 (fr)
ZA (1)	ZA917176B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9019875D0 (en) *	1990-09-11	1990-10-24	Glaxo Group Ltd	Pharmaceutical compositions
GB9120131D0 (en) *	1991-09-20	1991-11-06	Glaxo Group Ltd	Medicaments
ES2130152T3 (es) *	1991-12-06	1999-07-01	Glaxo Group Ltd	Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
GB9127150D0 (en) *	1991-12-20	1992-02-19	Smithkline Beecham Plc	Novel treatment
CA2211873A1 (fr) *	1995-01-26	1996-08-01	Michael Droege	Composes de bismuth
GB9501560D0 (en) *	1995-01-26	1995-03-15	Nycomed Imaging As	Contrast agents
AU1513699A (en) *	1998-08-18	2000-03-14	Nikolai Borisovich Leonidov	Physically stable and x-ray amorphous form of hydrochloride ranitidine having anincreased antitumoral activity and method for producing the same
EP1104673A1 (fr) *	1999-11-30	2001-06-06	Bayer Classics	Composition pharmaceutique sans agent desintégrant contenant un bicarbonate
KR100412290B1 (ko) *	2001-11-27	2003-12-31	주식회사 동구제약	라니티딘 함유 현탁제 조성물 및 그의 제조방법
US20060100271A1 (en) *	2004-11-08	2006-05-11	Keith Whitehead	Stabilized aqueous ranitidine compositions
US9629809B2 (en)	2008-07-21	2017-04-25	Si Group, Inc.	High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
CA2730005C (fr)	2008-07-21	2017-06-13	Albermarle Corporation	Granules d'ibuprofene sodique a teneur, leur preparation et leur utilisation dans la preparation de formes posologiques solides non effervescentes
US20230218663A1 (en) *	2020-06-01	2023-07-13	The University Of Hong Kong	Compositions and methods for treating a sars-cov-2 infection

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4608257A (en) *	1984-01-03	1986-08-26	Board Of Regents For Oklahoma State University	Composition and method for treating heat stress
GB8629781D0 (en) *	1986-12-12	1987-01-21	Glaxo Group Ltd	Pharmaceutical compositions
EP0282132B1 (fr) *	1987-03-09	1992-09-30	The Procter & Gamble Company	Compositions et leur utilisation dans le traitement d'affections gastrointestinales
DE3710462A1 (de) *	1987-03-30	1988-10-13	Heumann Pharma Gmbh & Co	Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
FR2633181B1 (fr) *	1988-06-24	1992-01-10	Glaxo Lab Sa	Composition pharmaceutique a base de ranitidine et son procede de preparation
CH679582A5 (fr) *	1988-07-18	1992-03-13	Glaxo Group Ltd
EP0363502B1 (fr) *	1988-10-08	1991-09-25	Dr. R. Pfleger Chemische Fabrik Gmbh	Formulation liquide contenant du bismuth, procédé pour la préparer et son utilisation
AU641903B2 (en) *	1988-10-26	1993-10-07	Glaxo Group Limited	Carboxylic acid derivatives
US5013560A (en) *	1989-03-17	1991-05-07	The Procter & Gamble Company	Microbially-stable bismuth-containing liquid pharmaceutical suspensions
GB9019875D0 (en) *	1990-09-11	1990-10-24	Glaxo Group Ltd	Pharmaceutical compositions

1990
- 1990-09-11 GB GB909019875A patent/GB9019875D0/en active Pending
1991
- 1991-09-06 IL IL9942891A patent/IL99428A/en not_active IP Right Cessation
- 1991-09-09 CA CA002050970A patent/CA2050970C/fr not_active Expired - Fee Related
- 1991-09-10 DK DK159191A patent/DK159191A/da not_active Application Discontinuation
- 1991-09-10 ZA ZA917176A patent/ZA917176B/xx unknown
- 1991-09-10 FR FR9111146A patent/FR2666508B1/fr not_active Expired - Fee Related
- 1991-09-10 CH CH2655/91A patent/CH683068A5/fr not_active IP Right Cessation
- 1991-09-10 JP JP3230571A patent/JPH0692849A/ja active Pending
- 1991-09-10 IT ITRM910673A patent/IT1249696B/it active IP Right Grant
- 1991-09-10 IE IE319191A patent/IE65049B1/en not_active IP Right Cessation
- 1991-09-10 GB GB9119284A patent/GB2248185B/en not_active Expired - Fee Related
- 1991-09-10 KR KR1019910015760A patent/KR100196308B1/ko not_active IP Right Cessation
- 1991-09-10 SE SE9102604A patent/SE509694C2/sv not_active IP Right Cessation
- 1991-09-10 AU AU83757/91A patent/AU640816B2/en not_active Ceased
- 1991-09-10 BE BE9100841A patent/BE1005115A5/fr not_active IP Right Cessation
- 1991-09-10 NZ NZ239731A patent/NZ239731A/en unknown
- 1991-09-10 NL NL9101533A patent/NL194907C/nl not_active IP Right Cessation
- 1991-09-10 DE DE4130061A patent/DE4130061A1/de not_active Withdrawn
- 1991-09-10 AT AT0180191A patent/AT405134B/de not_active IP Right Cessation
1992
- 1992-01-30 NO NO920408A patent/NO179694C/no not_active IP Right Cessation
- 1992-03-05 MX MX9101009A patent/MX9101009A/es unknown
- 1992-03-05 DE DE69202696T patent/DE69202696D1/de not_active Expired - Lifetime
- 1992-03-05 RO RO94-01459A patent/RO112084B1/ro unknown
- 1992-03-05 EP EP92103741A patent/EP0558779B1/fr not_active Expired - Lifetime
- 1992-03-05 AU AU13347/92A patent/AU1334792A/en not_active Abandoned
- 1992-03-05 AT AT92103741T patent/ATE122883T1/de not_active IP Right Cessation
- 1992-03-05 WO PCT/EP1992/000498 patent/WO1993017679A1/fr active IP Right Grant
- 1992-03-05 SK SK1060-94A patent/SK279591B6/sk unknown
- 1992-03-05 ES ES92103741T patent/ES2072647T3/es not_active Expired - Lifetime
- 1992-03-05 RU RU94040869A patent/RU2108097C1/ru active
1994
- 1994-03-22 US US08/215,658 patent/US5456925A/en not_active Expired - Lifetime
- 1994-06-23 HK HK60894A patent/HK60894A/xx not_active IP Right Cessation
- 1994-08-12 OA OA60553A patent/OA10093A/en unknown
- 1994-09-01 BG BG99021A patent/BG61931B1/bg unknown
- 1994-09-02 FI FI944047A patent/FI944047A0/fi unknown
1995
- 1995-06-28 HU HU95P/P00511P patent/HU211846A9/hu unknown
1997
- 1997-09-05 CY CY198897A patent/CY1988A/en unknown

Also Published As

Publication number	Publication date
NL194907C (nl)	2003-07-04
NL9101533A (nl)	1992-04-01
IT1249696B (it)	1995-03-09
KR100196308B1 (ko)	1999-06-15
SK106094A3 (en)	1995-02-08
GB2248185A (en)	1992-04-01
NO920408L (no)	1993-08-02
US5456925A (en)	1995-10-10
FR2666508B1 (fr)	1994-02-18
GB2248185B (en)	1994-02-02
ATE122883T1 (de)	1995-06-15
ATA180191A (de)	1998-10-15
RU2108097C1 (ru)	1998-04-10
NO179694C (no)	1996-12-04
CA2050970A1 (fr)	1992-03-12
NO920408D0 (no)	1992-01-30
NZ239731A (en)	1993-10-26
IL99428A (en)	1996-06-18
IE65049B1 (en)	1995-10-04
GB9119284D0 (en)	1991-10-23
CH683068A5 (fr)	1994-01-14
DK159191D0 (da)	1991-09-10
FI944047A (fi)	1994-09-02
RO112084B1 (ro)	1997-05-30
EP0558779A1 (fr)	1993-09-08
EP0558779B1 (fr)	1995-05-24
NO179694B (no)	1996-08-26
MX9101009A (es)	1992-05-04
CY1988A (en)	1997-09-05
KR920005984A (ko)	1992-04-27
AU640816B2 (en)	1993-09-02
DK159191A (da)	1992-03-12
WO1993017679A1 (fr)	1993-09-16
FR2666508A1 (fr)	1992-03-13
BE1005115A5 (fr)	1993-04-27
JPH0692849A (ja)	1994-04-05
AU1334792A (en)	1993-10-05
IL99428A0 (en)	1992-08-18
ITRM910673A0 (it)	1991-09-10
HU211846A9 (en)	1995-12-28
SK279591B6 (sk)	1999-01-11
ITRM910673A1 (it)	1993-03-10
AT405134B (de)	1999-05-25
ES2072647T3 (es)	1995-07-16
HK60894A (en)	1994-07-08
CA2050970C (fr)	2002-11-19
AU8375791A (en)	1992-03-19
GB9019875D0 (en)	1990-10-24
DE4130061A1 (de)	1992-03-12
OA10093A (en)	1996-12-18
NL194907B (nl)	2003-03-03
SE9102604L (sv)	1992-03-12
SE9102604D0 (sv)	1991-09-10
FI944047A0 (fi)	1994-09-02
SE509694C2 (sv)	1999-02-22
DE69202696D1 (de)	1995-06-29
IE913191A1 (en)	1992-04-22
ZA917176B (en)	1992-06-24
BG99021A (bg)	1995-06-30

Publication	Publication Date	Title
BG61931B1 (bg)	1998-10-30	Фармацевтични състави, съдържащи производни на фурана
JPH0482832A (ja)	1992-03-16	医薬組成物
US5466436A (en)	1995-11-14	Medicaments for treating inflammatory conditions or for analgesia
US5002946A (en)	1991-03-26	Phenylethanolamine analog active compounds for the treatment of gastrointestinal diseases
RU94040869A (ru)	1997-11-10	Фармацевтические композиции, содержащие соли ранитидина и карбоксилаты висмута, и способ их получения
US5728401A (en)	1998-03-17	Effervescent ranitidine formulations
JPH08512321A (ja)	1996-12-24	Ｈ▲下２▼拮抗剤−アルギネート−制酸剤の組合せ物
RU2197244C2 (ru)	2003-01-27	Фармацевтическая композиция и фармацевтический препарат, содержащие калиевую, натриевую и трис соли оксапрозина, их применение для устранения или уменьшения боли у млекопитающего и для лечения воспаления и нарушений, связанных с воспалением у млекопитающего, способ получения фармацевтического препарата
US3993778A (en)	1976-11-23	Anti-ulcerogenic pharmaceutical compositions containing a 2-amino-3,5-dibromo-benzylamine and method of use
CZ281514B6 (cs)	1996-10-16	Farmaceutický prostředek
CA1108992A (fr)	1981-09-15	Composition pharmaceutique contenant du 1,3-bis(2- carboxychromone-5-yloxy)2-hydroxypropane
HU217587B (hu)	2000-02-28	Ranitidint és bizmut-karboxilát-komplexet, valamint bázisos sókat tartalmazó gyógyászati készítmények
JPS63233919A (ja)	1988-09-29	薬学的組成物
KR100593795B1 (ko)	2006-06-30	안정성이 개선된 라미프릴을 포함하는 경구투여용 제제
RU2134579C1 (ru)	1999-08-20	Лекарственные средства для лечения воспалительных состояний или для анальгезии